Dr. Michael Zemel is the Chief Scientific Officer at Kinexum.
He currently also serves as the Chief Scientific Officer at NuSirt Sciences, which he co-founded. Through this position, he has experience in the discovery R&D program in metabolic health and clinical stage asset development in obesity, diabetes and MASH. He also leads clinical program development and regulatory effort through Phase 2 in each of the company’s therapeutic areas. Before starting NuSirt, Dr. Zemel served as Professor of Medicine and Nutrition at the University of Tennessee. Prior to that, he was Professor of Endocrinology and Nutrition at Wayne State University, with a concurrent position as Research Endocrinologist at the VA.
Dr. Zemel has authored or co-authored more than 200 clinical and basic peer-reviewed publications in numerous journals, including Proceedings of the National Academy of Sciences, New England Journal of Medicine, American Journal of Physiology, Endocrinology, Journal of Clinical Investigation, American Journal of Hypertension, PLoSOne, FASEB Journal, Metabolism, and Obesity. He holds B.S., M.S. and Ph.D. degrees from the University of Wisconsin-Madison.